All Janssen HME Forum webinars

How do we ensure we choose the right treatment for the right patient?

4 October 2022 - 46 Minutes

Faculty

Mohamad Mohty

Faith Davies

Charlotte Pawlyn

EM-93604

Challenges in CLL: How risk stratification can guide the choice of first-line treatment in patients with CLL

13 September 2022 - 47 Minutes

Faculty

John Gribben

Carol Moreno

Ruth Clifford

Paolo Sportoletti

EM-93552

MRD - What will change in the next year?

5 July 2022 - 45 Minutes

Faculty

Mohamad Mohty

Fredrik Schjesvold

EM-93560

Highlights from EHA 2022: Expert insights and clinical implications for the management of patients with multiple myeloma

22 June 2022 - 64 Minutes

Faculty

María Victoria Mateos

Saad Zafar Usmani

Niels van de Donk

EM-93557

Challenges in CLL: how does the data from EHA 2022 inform key management questions?

21 June 2022 - 63 Minutes

Faculty

John Gribben

Paolo Ghia

EM-78442

Challenges in NHL: how does the data from EHA 2022 inform key management questions?

20 June 2022 - 1 Hours

Faculty

Georg Hess

Christian Buske

EM-78670

Challenges in NHL: managing WM-associated complications: a case study-based discussion

31 May 2022 - 51 Minutes

Faculty

Christian Buske

Véronique Leblond

Roger Owen

EM-78665

Bispecific antibodies: raising new horizons for RRMM?

19 May 2022 - 47 Minutes

Faculty

María Victoria Mateos

Niels van de Donk

Ajai Chari

EM-88730

Challenges in CLL: What does the future hold - are we approaching cure in CLL?

17 May 2022 - 46 Minutes

Faculty

John Gribben

Stephan Stilgenbauer

EM-78439

Practical considerations around CAR T-cell therapies for patients with multiple myeloma

12 May 2022 - 48 Minutes

Faculty

Michel Delforge

Paula Rodriguez Otero

Max Topp

EM-78417

1
2
3